C07J 1/00
Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position
Official title: Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
C07J1/00 (Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position) appears on 1,048 US grants and 791 published applications in this corpus.
Search patents in C07J- Granted patents
- 1,048
- Published applications
- 791
- Assignees
- 482
- Inventors
- 1,984
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 54 | 0 |
| 1977 | 38 | 0 |
| 1978 | 38 | 0 |
| 1979 | 21 | 0 |
| 1980 | 32 | 0 |
| 1981 | 29 | 0 |
| 1982 | 31 | 0 |
| 1983 | 17 | 0 |
| 1984 | 22 | 0 |
| 1985 | 23 | 0 |
| 1986 | 17 | 0 |
| 1987 | 14 | 0 |
| 1988 | 13 | 0 |
| 1989 | 22 | 0 |
| 1990 | 22 | 0 |
| 1991 | 12 | 0 |
| 1992 | 24 | 0 |
| 1993 | 17 | 0 |
| 1994 | 13 | 0 |
| 1995 | 17 | 0 |
| 1996 | 29 | 0 |
| 1997 | 23 | 0 |
| 1998 | 38 | 0 |
| 1999 | 20 | 0 |
| 2000 | 15 | 0 |
| 2001 | 11 | 2 |
| 2002 | 15 | 33 |
| 2003 | 21 | 42 |
| 2004 | 23 | 56 |
| 2005 | 16 | 45 |
| 2006 | 33 | 27 |
| 2007 | 16 | 35 |
| 2008 | 13 | 36 |
| 2009 | 17 | 22 |
| 2010 | 17 | 22 |
| 2011 | 14 | 19 |
| 2012 | 14 | 20 |
| 2013 | 12 | 32 |
| 2014 | 12 | 36 |
| 2015 | 21 | 33 |
| 2016 | 19 | 37 |
| 2017 | 21 | 34 |
| 2018 | 26 | 29 |
| 2019 | 21 | 28 |
| 2020 | 14 | 27 |
| 2021 | 21 | 39 |
| 2022 | 20 | 26 |
| 2023 | 17 | 25 |
| 2024 | 13 | 31 |
| 2025 | 15 | 29 |
| 2026 | 5 | 26 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Androgen receptor modulators6 Oct 2026US 12,753,202 B2Trustees of Dartmouth College
- Orally active leukemia inhibitory factor (LIF) antagonists for the treatment of cancer29 Sep 2026US 12,747,263 B2Evestra, Inc.
- C17, C20, and C21 substituted neuroactive steroids and their methods of use16 Jun 2026US 12,655,175 B2Sage Therapeutics, Inc.
- 2-methoxyestradiol derivatives and medical uses thereof10 Mar 2026US 12,570,685 B2Institut Pasteur Korea
- Compositions and methods for treating CNS disorders27 Jan 2026US 12,534,495 B2Sage Therapeutics, Inc.
- Lymph directing prodrugs24 Sep 2026US 2026/0284004 A1Monash University
- Organic Photoredox Catalysts, Compositions, and Conversion Processes24 Sep 2026US 2026/0284647 A1Colorado State University Research Foundation
- Process For The Purification Of 2-Methoxyestradiol From 4- Methoxyestradiol And Intermediates Of The Process24 Sep 2026US 2026/0285896 A1Industriale Chimica S.R.L.
- Methods for the Epigenetic Analysis of DNA, Particularly Cell-Free DNA24 Sep 2026US 2026/0286421 A1Clearnote Health, Inc.
- Process and intermediates for the preparation of 3alpha-hydroxy-3beta-alkyl steroids3 Sep 2026US 2026/0258072 A1Curia Spain, S.A.U.
Most cited
By later US patents
- 1,3-propane diol esters and ethers and methods for their use in drug delivery162US 6,555,700 B1Scotia Holdings PLC · 2003
- Fatty acid esters as bioactive compounds147US 6,245,811 B1Scotia Holdings PLC · 2001
- Anti-estrogenic compounds and compositions119US 5,395,842 AEndorecherche, Inc. · 1995
- Neuroactive steroids of the androstane and pregnane series114US 5,925,630 ACoCensys, Inc. · 1999
- Estrogenic compounds as anti-angiogenic agents112US 5,504,074 AChildren's Medical Center Corporation · 1996